Impact of prolonged implantable cardioverter-defibrillator arrhythmia detection times on outcomes: A meta-analysis

Heart Rhythm

Volumn 11, Issue 5, 2014, Pages 828-835

  Scott, Paul A ^a   Silberbauer, John ^a   McDonagh, Theresa A ^a,b   Murgatroyd, Francis D ^a,b  

^a KING S COLLEGE HOSPITAL   (United Kingdom)

^b KING'S COLLEGE LONDON   (United Kingdom)

Author keywords

Arrhythmia; Coronary artery disease; Implantable cardioverter defibrillator; Meta analysis; Sudden death

Indexed keywords

ADVERSE OUTCOME; ARTICLE; CONVULSIVE THERAPY; DEATH; FAINTNESS; FOLLOW UP; HEART ARRHYTHMIA; HEART RATE; HUMAN; IMPLANTABLE CARDIOVERTER DEFIBRILLATOR; META ANALYSIS; MORTALITY; OUTCOME ASSESSMENT; PRIORITY JOURNAL; RISK FACTOR; SHOCK; SUPRAVENTRICULAR TACHYCARDIA; ARRHYTHMIAS, CARDIAC; CAUSE OF DEATH; DEATH, SUDDEN, CARDIAC; HEALTH; INCIDENCE;

ARRHYTHMIAS, CARDIAC; CAUSE OF DEATH; DEATH, SUDDEN, CARDIAC; DEFIBRILLATORS, IMPLANTABLE; GLOBAL HEALTH; HUMANS; INCIDENCE;

EID: 84899427183     PISSN: 15475271     EISSN: 15563871     Source Type: Journal    
DOI: 10.1016/j.hrthm.2014.02.009     Document Type: Article

References (23)

1. D.B. Mark, K.J. Anstrom, J.L. Sun, N.E. Clapp-Channing, A.A. Tsiatis, L. Davidson-Ray, K.L. Lee, and G.H. Bardy Quality of life with defibrillator therapy or amiodarone in heart failure N Engl J Med 359 2008 999 1008
2. J.E. Poole, G.W. Johnson, and A.S. Hellkamp et al. Prognostic importance of defibrillator shocks in patients with heart failure N Engl J Med 359 2008 1009 1017
3. R.T. Borne, P.D. Varosy, and F.A. Masoudi Implantable cardioverter-defibrillator shocks: epidemiology, outcomes, and therapeutic approaches JAMA 173 2013 859 865
4. A.J. Moss, C. Schuger, and C.A. Beck et al. Reduction in inappropriate therapy and mortality through ICD programming N Engl J Med 367 2012 2275 2283
5. M. Madhavan, and P.A. Friedman Optimal programming of implantable cardiac-defibrillators Circulation 128 2013 659 672
6. J.P.T. Higgins, D.G. Altman, P.C. Gotzsche, P. Juni, D. Moher, A.D. Oxman, J. Savovic, K.F. Schulz, L. Weeks, and JAC. Sterne The Cochrane Collaboration's tool for assessing risk of bias in randomised trials BMJ 343 2011 d5928
7. R. DerSimonian, and N. Laird Meta-analysis in clinical trials Control Clin Trials 7 1986 177 188
8. M. Gasparini, C. Menozzi, A. Proclemer, M. Landolina, S. Iacopino, A. Carboni, E. Lombardo, Fo Regoli, M. Biffi, V. Burrone, A. Denaro, and G. Boriani A simplified biventricular defibrillator with fixed long detection intervals reduces implantable cardioverter defibrillator (ICD) interventions and heart failure hospitalizations in patients with non-ischaemic cardiomyopathy implanted for primary prevention: the relevant [role of long detection window programming in patients with left ventricular dysfunction, non-ischemic etiology in primary prevention treated with a biventricular ICD] study Eur Heart J 30 2009 2758 2767
9. Higgins JPT, Green S, editors. Cochrane Handbook for Systematic Reviews of Interventions, version 5.1.0 [Updated March 2011]. The Cochrane Collaboration, 2011. Available from http://www.Cochrane-handbook.Org.
10. J.P. Higgins, S.G. Thompson, J.J. Deeks, and D.G. Altman Measuring inconsistency in meta-analyses BMJ 327 2003 557 560
11. B.L. Wilkoff, B.D. Williamson, R.S. Stern, S.L. Moore, F. Lu, S.W. Lee, U.M. Birgersdotter-Green, M.S. Wathen, I.C. Van Gelder, B.M. Heubner, M.L. Brown, and K.K. Holloman Strategic programming of detection and therapy parameters in implantable cardioverter-defibrillators reduces shocks in primary prevention patients: results from the prepare (primary prevention parameters evaluation) study J Am Coll Cardiol 52 2008 541 550
12. N. Clementy, B. Pierre, Bnd Lallemand, O. Marie, E. Lemoine, P. Cosnay, L. Fauchier, and D. Babuty Long-term follow-up on high-rate cut-off programming for implantable cardioverter defibrillators in primary prevention patients with left ventricular systolic dysfunction Europace 14 2012 968 974
13. S. Gonzalez-Enriquez, F. Rodriguez-Entem, V. Exposito, C. Castrillo-Bustamante, A. Canteli, A. Solloso, I. Madrazo, and J.J. Olalla Single-chamber ICD, single-zone therapy in primary and secondary prevention patients: the simpler the better? J Interv Card Electrophysiol 35 2012 343 349
14. B.L. Wilkoff, K.T. Ousdigian, L.D. Sterns, Z.J. Wang, R.D. Wilson, and J.M. Morgan A comparison of empiric to physician-tailored programming of implantable cardioverter-defibrillators: results from the prospective randomized multicenter empiric trial J Am Coll Cardiol 48 2006 330 339
15. J. Buber, D. Luria, O. Gurevitz, D. Bar-Lev, M. Eldar, and M. Glikson Safety and efficacy of strategic implantable cardioverter-defibrillator programming to reduce the shock delivery burden in a primary prevention patient population Europace 16 2014 227 234
16. M. Gasparini, A. Proclemer, and C. Klersy et al. Effect of long-detection interval vs standard-detection interval for implantable cardioverter- defibrillators on antitachycardia pacing and shock delivery: the Advance III randomized clinical trial JAMA 309 2013 1903 1911
17. M. Saeed, I. Hanna, D. Robotis, R. Styperek, L.E.O. Polosajian, A. Khan, J. Alonso, Y. Nabutovsky, and C. Neason Programming implantable cardioverter-defibrillators in patients with primary prevention indication to prolong time to first shock: results from the PROVIDE study J Cardiovasc Electrophysiol 25 2014 52 59
18. E.B. Schron, D.V. Exner, Q. Yao, L.S. Jenkins, J.S. Steinberg, J.R. Cook, S.P. Kutalek, P.L. Friedman, R.S. Bubien, R.L. Page, and J. Powell Investigators tA. Quality of life in the Antiarrhythmics Versus Implantable Defibrillators trial: impact of therapy and influence of adverse symptoms and defibrillator shocks Circulation 105 2002 589 594
19. F. Mansour, and P. Khairy Programming ICDs in the modern era beyond out-of-the box settings Pacing Clin Electrophysiol 34 2011 506 520
20. J.P. Daubert, W. Zareba, and D.S. Cannom et al. Inappropriate implantable cardioverter-defibrillator shocks in MADIT II: frequency, mechanisms, predictors, and survival impact J Am Coll Cardiol 51 2008 1357 1365
21. J.B. van Rees, C.J.W. Borleffs, M.l.K. de Bie, T. Stijnen, L. van Erven, J.J. Bax, and M.J. Schalij Inappropriate implantable cardioverter-defibrillator shocks: incidence, predictors, and impact on mortality J Am Coll Cardiol 57 2011 556 562
22. B.D. Powell, L.A. Saxon, J.P. Boehmer, J.D. Day, F.R. Gilliam Iii, P.A. Heidenreich, P.W. Jones, M.J. Rousseau, and D.L. Hayes Survival after shock therapy in implantable cardioverter-defibrillator and cardiac resynchronization therapy-defibrillator recipients according to rhythm shocked: the Altitude Survival by Rhythm study J Am Coll Cardiol 62 2013 1674 1679
23. M.S. Wathen, P.J. DeGroot, M.O. Sweeney, A.J. Stark, M.F. Otterness, W.O. Adkisson, R.C. Canby, K. Khalighi, C. Machado, D.S. Rubenstein, and K.J. Volosin PainFREE Rx II Investigators. Prospective randomized multicenter trial of empirical antitachycardia pacing versus shocks for spontaneous rapid ventricular tachycardia in patients with implantable cardioverter- defibrillators: Pacing Fast Ventricular Tachycardia Reduces Shock Therapies (PainFREE Rx II) trial results Circulation 110 2004 2591 2596